GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (FRA:HPX) » Definitions » Other Stockholders Equity

Hisamitsu Pharmaceutical Co (FRA:HPX) Other Stockholders Equity : €300.2 Mil (As of Feb. 2024)


View and export this data going back to . Start your Free Trial

What is Hisamitsu Pharmaceutical Co Other Stockholders Equity?

Hisamitsu Pharmaceutical Co's Other Stockholders Equity for the quarter that ended in Feb. 2024 was €300.2 Mil.

Hisamitsu Pharmaceutical Co's quarterly Other Stockholders Equity increased from Aug. 2023 (€315.4 Mil) to Nov. 2023 (€324.0 Mil) but then declined from Nov. 2023 (€324.0 Mil) to Feb. 2024 (€300.2 Mil).

Hisamitsu Pharmaceutical Co's annual Other Stockholders Equity increased from Feb. 2022 (€196.2 Mil) to Feb. 2023 (€260.8 Mil) and increased from Feb. 2023 (€260.8 Mil) to Feb. 2024 (€300.2 Mil).


Hisamitsu Pharmaceutical Co Other Stockholders Equity Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Other Stockholders Equity Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 161.07 153.74 196.19 260.83 300.20

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 260.83 264.72 315.44 324.03 300.20

Hisamitsu Pharmaceutical Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Hisamitsu Pharmaceutical Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (FRA:HPX) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.